AZD5462 clinical trials

A Phase IIb Two-cohort, Randomised, Placebo-controlled, Double-blind, Multi-centre, Dose-ranging Study of AZD5462 in Stable Patients with Chronic Heart Failure

This study is testing a new medicine, AZD5462, for people with long-term heart failure. Researchers want to see if it improves how well the heart pumps, using ultrasound scans. It's a key step to understanding if this medicine could help patients.